Journal Information
Vol. 40. Issue 2.
Pages 51-53 (February 2004)
Vol. 40. Issue 2.
Pages 51-53 (February 2004)
Editorial
Full text access
Management of End-Stage Lung Disease
Visits
21402
A. Pacheco Galván*
Unidad de Trasplante Pulmonar, Servicio de Neumología, Hospital Ramón y Cajal, Madrid, Spain
This item has received
Article information
Full text is only aviable in PDF
REFERENCES
[1]
JD Hosenpud, LE Bennett, BM Keck, B Fiol, MM Boucek, RJ Novick.
The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report 1998.
J Heart Lung Transplant, 17 (1998), pp. 656-668
[2]
DE Low, EP Trulock, LR Kaiser, MK Pasque, NA Ettinger, C Dresler, et al.
Lung transplantation of ventilator dependent patients.
Chest, 101 (1992), pp. 8-11
[3]
American Thoracic Society.
International guidelines for the selection of lung transplant candidates.
Am J Respir Crit Care Med, 158 (1998), pp. 335-339
[4]
TP Toma, PG Goldstraw, DM Geddes.
Lung volume reduction surgery [editorial].
Thorax, 57 (2002), pp. 5
[5]
P De Lucas Ramos.
¿Cuánto debe durar la rehabilitación respiratoria? [editorial].
Arch Bronconeumol, 37 (2001), pp. 459-461
[6]
AF Connors, NV Dawson, C Thomas, FE Harrell, N Desbiens, WJ Fulkerson, et al.
Outcomes following acute exacerbations of severe chronic obstructive lung disease.
Am J Respir Crit Care Med, 154 (1996), pp. 959-967
[7]
V Calvo, J Padilla, A García-Zarza, E Blasco, J Pastor, Paris F y Grupo de Trasplante Pulmonar de Valencia.
El trasplante pulmonar en situación de urgencia.
Arch Bronconeumol, 39 (2003), pp. 111-114
[8]
RA Pauwels, AS Buist, PMA Calverley, CR Jenkins, SS Hurd.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 163 (2001), pp. 1256-1276
[9]
G O'Brien, GJ Criner.
Mechanical ventilation as a bridge to lung transplantation.
J Heart Lung Transplant, 18 (1999), pp. 255-265
[10]
National Emphysema Treatment Trial Research Group.
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.
N Engl J Med, 348 (2003), pp. 2059-2073
[11]
American Thoracic Society, European Respiratory Society.
Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement.
Am J Respir Crit Care Med, 161 (2000), pp. 646-664
[12]
AG Nicholson, LG Fulford, TV Colby, RM Du Bois, DM Hansell, AU Wells.
The relation between individual histologic features and disease progression in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med, 166 (2002), pp. 173-177
[13]
KR Flaherty, EL Thwaite, EA Kazerooni, BH Gross, GB Toews, TV Colby, et al.
Radiological versus histological diagnosis in UIP and NISP: survival implications.
Thorax, 58 (2003), pp. 143-148
[14]
JH Newman.
Treatment of primary pulmonary hypertension—the next generation [editorial].
N Engl J Med, 346 (2002), pp. 933-935
[15]
P Ussetti, A Varela.
Alternativas quirúrgicas en el tratamiento de la hipertensión pulmonar grave.
Arch Bronconeumol, 38 (2002), pp. 33-38
[16]
JA Dodge, S Morison, PA Lewis, EC Colest, D Geddes, G Russell, et al.
Cystic fibrosis in the United Kingdom, 1968-1988: incidence, population and survival.
Paediatric Perinatal Epidem, 7 (1993), pp. 157-166
Copyright © 2004. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)